Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/17446651.2021.1927708 http://scihub22266oqcxt.onion/10.1080/17446651.2021.1927708 34096441!ä!34096441 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Expert+Rev+Endocrinol+Metab 2021 ; 16 (4): 181-189 Nephropedia Template TP {{tp|p=34096441|t=2021. Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives |pdf=|usr=}}{{34096441}} gab.com Text Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives JO: Expert Rev Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=34096441 #FOAvip Introduction: The COVID-19 pandemic has affected the entire population with the most deleterious effects in elders. Elders, especially those with diabetes, are at the highest risk of COVID-19 related adverse outcomes and mortality. This is usually linked to the comorbidities that accumulate with age, diabetes-related chronic inflammation, and the pandemic's psychosocial effects.Areas covered: We present some approaches to manage these complicated elderly patients with diabetes during the COVID-19 pandemic. In the inpatient setting, we suggest similar (pre-pandemic) glycemic targets and emphasize the importance of using IV insulin and possible use of continuous glucose monitoring to reduce exposure and PPE utilization. Outside the hospital, we recommend optimal glycemic control within the limits imposed by considerations of safety. We also describe the advantages and challenges of using various technological platforms in clinical care.Expert opinion: The COVID-19 pandemic has lifted the veil off serious deficiencies in the infrastructures for care at both the individual level and the population level and also highlighted some of the strengths, all of which affect individuals with diabetes and COVID-19. We anticipate that things will not return to 'normal' after the COVID-19 pandemic has run its course, but rather they will be superseded by 'New Normal.' Twit Text FOAVip Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives ????Expert Rev Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=34096441 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34096441 #FOAvip English Wikipedia <ref>{{Cite pmid|34096441}}</ref> Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives #MMPMID34096441 Rajpal A; Sayyed Kassem L; Aron DC Expert Rev Endocrinol Metab 2021[Jul]; 16 (4): 181-189 PMID34096441show ga Introduction: The COVID-19 pandemic has affected the entire population with the most deleterious effects in elders. Elders, especially those with diabetes, are at the highest risk of COVID-19 related adverse outcomes and mortality. This is usually linked to the comorbidities that accumulate with age, diabetes-related chronic inflammation, and the pandemic's psychosocial effects.Areas covered: We present some approaches to manage these complicated elderly patients with diabetes during the COVID-19 pandemic. In the inpatient setting, we suggest similar (pre-pandemic) glycemic targets and emphasize the importance of using IV insulin and possible use of continuous glucose monitoring to reduce exposure and PPE utilization. Outside the hospital, we recommend optimal glycemic control within the limits imposed by considerations of safety. We also describe the advantages and challenges of using various technological platforms in clinical care.Expert opinion: The COVID-19 pandemic has lifted the veil off serious deficiencies in the infrastructures for care at both the individual level and the population level and also highlighted some of the strengths, all of which affect individuals with diabetes and COVID-19. We anticipate that things will not return to 'normal' after the COVID-19 pandemic has run its course, but rather they will be superseded by 'New Normal.' |Administration, Intravenous[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Blood Glucose Self-Monitoring/methods[MESH] |Blood Glucose/analysis[MESH] |COVID-19/diagnosis/epidemiology/mortality/*psychology[MESH] |Chronic Disease[MESH] |Comorbidity[MESH] |Diabetes Mellitus/diagnosis/*drug therapy/epidemiology[MESH] |Disease Management[MESH] |Humans[MESH] |Hypoglycemic Agents/administration & dosage/therapeutic use[MESH] |Inflammation/*complications[MESH] |Insulin/administration & dosage/therapeutic use[MESH] |Patient Education as Topic/methods[MESH] |Personal Protective Equipment/*ethics/standards[MESH] |Prevalence[MESH] |Risk Assessment[MESH] |SARS-CoV-2/genetics/isolation & purification[MESH]Management of diabetes in elderly patients during the COVID-19 pandemi(epmc).pdf DeepDyve Pubget Overpricing